M

Mineralys Therapeutics, Inc.

16 employees

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Medical

Pharmaceutical

Biopharma

Date founded

2020

Funding rounds raised

Total raised

$118M

from 13 investors over 13 rounds

M

Mineralys Therapeutics, Inc. raised $118M on June 8, 2022

Investors: Sectoral Asset Management, HEALTHCOR LTD, Samsara BioCapital, Catalys Pacific, S.R. One Ltd, RA Capital Management, L.P., Ysios Capital and RTW Investments, LP

M

Mineralys Therapeutics, Inc. raised undisclosed on January 18, 2022

Investors: HBM Partners AG

M

Mineralys Therapeutics, Inc. raised $40M on April 6, 2021

Investors: Adams Street Partners, Samsara BioCapital and Catalys Pacific

M

Mineralys Therapeutics, Inc. raised $4M on April 6, 2021

Investors: Catalys Pacific